Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment

This study aimed to determine dolutegravir cerebrospinal fluid (CSF) diffusion in 13 patients with HIV-related cerebral impairment enrolled in a real-life observational study. Dolutegravir median (range) CSF concentration [9.6 (3.6–22.8) ng/mL] reached CSF therapeutic concentrations whatever the blo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Gelé, Thibaut, Furlan, Valérie, Taburet, Anne-Marie, Pallier, Coralie, Becker, Pierre-Hadrien, Goujard, Cécile, Gasnault, Jacques, Barrail-Tran, Aurélie, Chéret, Antoine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6546201/
https://ncbi.nlm.nih.gov/pubmed/31198814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz174
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak